GIC Sub-Industry »Biotechnology« (200+)
| Symbol | Industry | Market Cap | VRT | Buy Signal | Risk | RS (IBD) | Div. Yield |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie |
Biotechnology
Medicines, Therapies, Injectables |
398B | 34 | -0.80 | 49 | 35 | 3.3% |
| AMGN Amgen |
Biotechnology
Biologics, Treatments, Therapies |
197B | 59 | -0.12 | 54 | 72 | 3.1% |
| GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, Rare Diseases |
180B | 64 | -0.40 | 84 | 79 | 3.4% |
| NOV Novo Nordisk |
Biotechnology
Diabetes, Obesity, Rare Disease |
169B | 37 | -1.46 | 84 | 4 | 2.8% |
| VRTX Vertex |
Biotechnology
Medicines, Therapies, Treatments |
119B | 48 | -0.75 | 86 | 39 | - |
| REGN Regeneron |
Biotechnology
Eye Disease, Asthma, Cancer |
78.9B | 56 | -0.25 | 97 | 71 | 0.5% |
| HLN Haleon |
Biotechnology
Oral Care, Vitamins, Pain Relief |
46.6B | 53 | -0.96 | 89 | 50 | 1.8% |
| ARGX argenx |
Biotechnology
Biologics, Treatments, Autoimmune |
43.5B | 58 | -0.79 | 73 | 34 | - |
| ALNY Alnylam |
Biotechnology
RNAi Therapeutics, Onpattro |
41.6B | 54 | -0.75 | 32 | 24 | - |
| ONC BeiGene |
Biotechnology
Cancer Therapies, Immunotherapy |
32.8B | 40 | -1.04 | 43 | 31 | - |
| INSM Insmed |
Biotechnology
Rare Disease Therapies, Lung |
30.1B | 34 | -0.64 | 31 | 75 | - |
| BIIB Biogen |
Biotechnology
Neurology Drugs, Biosimilars, Rare |
26.6B | 57 | -0.20 | 92 | 77 | - |
| NTRA Natera |
Biotechnology
Prenatal Screening, Cancer |
26.6B | 56 | 0.19 | 37 | 58 | - |
| UTHR United Therapeutics |
Biotechnology
Treating Pulmonary Arterial |
23.5B | 62 | -0.23 | 82 | 87 | - |
| BNTX BioNTech SE |
Biotechnology
Cancer, Vaccines, Immunotherapy |
22.9B | 26 | -1.49 | 85 | 26 | - |
| MRNA Moderna |
Biotechnology
Vaccines, Oncology, Rare |
20.8B | 39 | 0.21 | 33 | 96 | - |
| ROIV Roivant Sciences |
Biotechnology
Medicines, Therapies, Antibodies |
20.4B | 50 | 0.03 | 88 | 97 | - |
| EXAS EXACT Sciences |
Biotechnology
Cancer Tests, Genetic Testing |
19.8B | 55 | 0.29 | 38 | 94 | - |
| RVMD Revolution |
Biotechnology
Cancer Therapies, Drug |
18.8B | 43 | -0.30 | 88 | 97 | - |
| INCY Incyte |
Biotechnology
Cancer Therapies, Dermatology |
18.5B | 70 | -0.22 | 87 | 72 | - |
| GMAB Genmab AS |
Biotechnology
Antibody Therapies, Cancer Drugs |
16.3B | 48 | -0.77 | 68 | 37 | - |
| ASND Ascendis Pharma AS |
Biotechnology
Endocrinology, Therapies, Rare |
13.9B | 52 | -0.26 | 33 | 77 | - |
| BBIO BridgeBio Pharma |
Biotechnology
Genetic Medicines, Small |
13.5B | 39 | -0.18 | 34 | 89 | - |
| NBIX Neurocrine |
Biotechnology
Neurological Drugs, Endocrine |
13.0B | 49 | 0.04 | 87 | 34 | - |
| BIM Biomerieux |
Biotechnology
Diagnostic Tests, Culture Media |
12.9B | 41 | -1.21 | 96 | 15 | 0.7% |
| SMMT Summit Therapeutics |
Biotechnology
Oncology Drug, Immunotherapy |
12.5B | 13 | -1.93 | 88 | 16 | - |
| ERF Eurofins |
Biotechnology
Testing, Laboratory, Analysis |
12.4B | 56 | -0.41 | 83 | 55 | 1.1% |
| IONS Ionis |
Biotechnology
RNA Medicines, Genetic Diseases |
11.8B | 46 | -0.52 | 61 | 89 | - |
| BMRN Biomarin |
Biotechnology
Rare Disease Therapies, Enzyme |
11.3B | 37 | -0.63 | 87 | 33 | - |
| EXEL Exelixis |
Biotechnology
Cancer Drugs, Targeted Therapies |
11.0B | 54 | -0.09 | 91 | 42 | - |
| MDGL Madrigal |
Biotechnology
Liver Drug, MASH Treatment |
10.2B | 28 | -0.44 | 29 | 63 | - |
| QIA QIAGEN |
Biotechnology
Diagnostics, Research Tools, Lab |
8.54B | 38 | -1.06 | 88 | 25 | 5.3% |
| PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.49B | 45 | -0.97 | 78 | 99 | - |
| ABVX Abivax American |
Biotechnology
Obefazimod |
8.19B | 32 | -0.57 | 43 | 99 | - |
| PCVX Vaxcyte |
Biotechnology
Vaccines, Pneumococcal, Bacterial |
8.16B | 29 | -0.74 | 88 | 83 | - |
| ABVX Abivax |
Biotechnology
Obefazimod, UlcerativeColitis |
7.98B | 34 | -0.89 | 43 | 99 | - |
| NUVL Nuvalent |
Biotechnology
Cancer Therapies, Drug Candidates |
7.82B | 36 | -0.54 | 87 | 68 | - |
| ARWR Arrowhead |
Biotechnology
RNAi, Hepatic, Metabolic |
7.71B | 58 | -0.17 | 33 | 98 | - |
| HALO Halozyme |
Biotechnology
Enzymes, Drug Delivery, Biologics |
7.51B | 45 | -0.48 | 83 | 36 | - |
| CYTK Cytokinetics |
Biotechnology
Muscle Activators, Muscle |
7.49B | 35 | -0.18 | 34 | 84 | - |
| KRYS Krystal Biotech |
Biotechnology
Genetic Medicines, Skin |
7.31B | 59 | -0.42 | 89 | 87 | - |
| ACLX Arcellx |
Biotechnology
Cancer Therapies, Immunotherapies |
6.70B | 45 | 0.29 | 82 | 95 | - |
| BLTE Belite Bio |
Biotechnology
Eye Disease, Liver Disease |
6.46B | 42 | 0.06 | 83 | 96 | - |
| KYMR Kymera Therapeutics |
Biotechnology
Drug Discovery, Protein |
6.45B | 44 | -0.56 | 88 | 91 | - |
| PTGX Protagonist |
Biotechnology
Oral Peptides, Injectable |
6.20B | 49 | 0.70 | 38 | 91 | - |
| RYTM Rhythm |
Biotechnology
Rare Diseases, Obesity |
6.18B | 38 | -0.80 | 43 | 61 | - |
| COGT Cogent Biosciences |
Biotechnology
Cancer Drugs, Genetic Therapies |
5.52B | 48 | -0.29 | 82 | 99 | - |
| MIRM Mirum |
Biotechnology
Rare Disease Treatments, Liver |
5.47B | 59 | -0.71 | 38 | 92 | - |
| CGON CG Oncology |
Biotechnology
Cancer Therapies, Bladder Cancer |
5.43B | 40 | 0.05 | 35 | 97 | - |
| PTCT PTC Therapeutics |
Biotechnology
Rare Disease Drugs, Gene Therapy |
5.34B | 55 | -0.25 | 61 | 59 | - |
| CELC Celcuity |
Biotechnology
Drug Candidates, Diagnostics |
5.28B | 58 | 0.28 | 82 | 99 | - |
| IMVT Immunovant |
Biotechnology
Antibodies, Treatments, Diseases |
5.09B | 34 | -0.83 | 38 | 76 | - |
| TGTX TG Therapeutics |
Biotechnology
Antibodies, Cancer Treatments |
5.03B | 20 | -0.78 | 28 | 23 | - |
| APGE Apogee |
Biotechnology
Biologics, Antibodies, Treatments |
4.95B | 43 | -0.83 | 85 | 86 | - |
| DIA DiaSorin S.p.A. |
Biotechnology
Diagnostic Kits, Molecular |
4.71B | 39 | -1.65 | 75 | 16 | 1.3% |
| CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapy, Drug |
4.68B | 23 | -1.46 | 88 | 28 | - |
| ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
4.63B | 31 | -0.96 | 78 | 25 | - |
| SRRK Scholar Rock |
Biotechnology
Antibody, Inhibitor, Myostatin |
4.60B | 21 | -1.11 | 80 | 56 | - |
| XENE Xenon |
Biotechnology
Neurological Therapeutics |
4.59B | 31 | -0.23 | 28 | 90 | - |
| ERAS Erasca |
Biotechnology
Cancer Therapies, Drug |
4.14B | 47 | 0.10 | 81 | 99 | - |
| CNTA Centessa |
Biotechnology
Medicines, Treatments |
4.13B | 42 | 0.27 | 38 | 91 | - |
| VKTX Viking Therapeutics |
Biotechnology
Metabolic Therapies, Endocrine |
4.11B | 22 | -2.05 | 88 | 68 | - |
| LGND Ligand |
Biotechnology
Antiviral, Oncology, Nephrology |
4.05B | 64 | 0.36 | 83 | 89 | - |
| GPCR Structure |
Biotechnology
Obesity Drugs, Fibrosis Drugs |
4.01B | 49 | -1.15 | 88 | 95 | - |
| CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
3.93B | 22 | -1.21 | 43 | 31 | - |
| INDV Indivior Ordinary |
Biotechnology
Extended-Release Injection |
3.89B | 66 | -0.32 | 45 | 94 | - |
| ACAD ACADIA |
Biotechnology
Antipsychotic, Trofinetide |
3.65B | 23 | -0.88 | 31 | 20 | - |
| ADMA ADMA Biologics |
Biotechnology
Biologics, Therapeutics, Plasma |
3.61B | 39 | -1.18 | 48 | 15 | - |
| KNSA Kiniksa |
Biotechnology
Cardiovascular Therapies, Skin |
3.50B | 54 | -0.40 | 56 | 88 | - |
| SYRE Spyre Therapeutics |
Biotechnology
Antibodies, Inflammatory Disease |
3.46B | 45 | -0.09 | 79 | 98 | - |
| LEGN Legend Biotech |
Biotechnology
Cell Therapies, Oncology, Cancer |
3.43B | 13 | -1.33 | 43 | 5 | - |
| NAMS NewAmsterdam |
Biotechnology
Cardiometabolic Therapies |
3.43B | 28 | -0.88 | 28 | 68 | - |
| DNTH Dianthus |
Biotechnology
Antibodies, Therapeutics |
3.37B | 37 | -0.11 | 43 | 99 | - |
| DNLI Denali Therapeutics |
Biotechnology
Neuro Drugs, Enzyme Therapy |
3.28B | 38 | -0.69 | 88 | 85 | - |
| EWTX Edgewise |
Biotechnology
Muscle Therapies, Cardiac |
3.19B | 33 | -0.32 | 88 | 93 | - |
| ALMS Alumis |
Biotechnology
TYK2 Inhibitor, Autoimmune Drug |
3.09B | 44 | -0.32 | 73 | 99 | - |
| DYN Dyne Therapeutics |
Biotechnology
Muscle Disease, Therapeutics |
2.99B | 44 | -0.68 | 80 | 82 | - |
| VRDN Viridian |
Biotechnology
Antibodies, Rare Diseases |
2.93B | 44 | -0.53 | 88 | 86 | - |
| IDYA Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Drug |
2.91B | 35 | -0.57 | 37 | 84 | - |
| CPRX Catalyst |
Biotechnology
Rare Disease Treatments, Seizure |
2.87B | 49 | 0.04 | 79 | 39 | - |
| VERA Vera Therapeutics |
Biotechnology
Biologics, Antibodies, Therapies |
2.85B | 40 | -1.15 | 88 | 80 | - |
| RCUS Arcus Biosciences |
Biotechnology
Antibody, Inhibitor, Cancer |
2.83B | 44 | -0.18 | 62 | 96 | - |
| ARQT Arcutis |
Biotechnology
Skin Treatments, Topical Creams |
2.82B | 43 | -1.10 | 31 | 73 | - |
| TWST Twist Bioscience |
Biotechnology
Synthetic DNA, Gene Synthesis |
2.65B | 28 | -1.09 | 42 | 85 | - |
| BEAM Beam Therapeutics |
Biotechnology
Gene Editing, Therapeutics, RNA |
2.63B | 35 | -0.86 | 83 | 64 | - |
| TVTX Travere |
Biotechnology
Sparsentan, Tiopronin, Filspari |
2.56B | 47 | -0.83 | 32 | 74 | - |
| VCYT Veracyte |
Biotechnology
Cancer Tests, Genomic Analysis |
2.55B | 33 | -0.16 | 43 | 32 | - |
| TNGX Tango Therapeutics |
Biotechnology
Oncology Drugs, Cancer Treatments |
2.47B | 46 | -0.11 | 75 | 99 | - |
| APLS Apellis |
Biotechnology
Eye Treatments, Blood Treatments |
2.42B | 27 | -1.29 | 33 | 13 | - |
| IMNM Immunome |
Biotechnology
Cancer Therapies, Drug Candidates |
2.30B | 46 | 0.00 | 88 | 96 | - |
| IRON Disc Medicine |
Biotechnology
Blood Disorders, Drug Development |
2.29B | 27 | -0.96 | 88 | 23 | - |
| GLPG Galapagos |
Biotechnology
Oncology Drugs, Immunology Drugs |
2.26B | 53 | -0.73 | 73 | 58 | - |
| DAWN Day One |
Biotechnology
Cancer Drugs, Clinical Trials |
2.20B | 38 | 0.28 | 31 | 99 | - |
| RARE Ultragenyx |
Biotechnology
Biologics, Gene Therapy, Enzyme |
2.11B | 13 | -1.75 | 43 | 3 | - |
| ZLAB Zai Lab |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
2.10B | 11 | -1.33 | 32 | 10 | - |
| SNDX Syndax |
Biotechnology
Cancer Therapies, Leukemia |
2.07B | 35 | -0.09 | 28 | 94 | - |
| MLYS Mineralys |
Biotechnology
Medicines, Treatments, Aldosterone |
2.04B | 42 | -1.00 | 70 | 48 | - |
| ORKA Oruka Therapeutics |
Biotechnology
Antibodies, Inflammation |
2.02B | 44 | -0.16 | 70 | 99 | - |
| CLDX Celldex |
Biotechnology
Antibodies, Therapeutics |
1.96B | 29 | -0.88 | 38 | 78 | - |
| TYRA Tyra Biosciences |
Biotechnology
Biologics, Therapies, Oncology |
1.95B | 46 | 0.70 | 88 | 99 | - |
| MESO Mesoblast |
Biotechnology
Cell Therapy, Inflammation, Heart |
1.94B | 7 | -0.96 | 33 | 32 | - |
| ZBIO Zenas BioPharma |
Biotechnology
Antibodies, Therapies, Immunology |
1.91B | 42 | -0.55 | 77 | 93 | - |
| STOK Stoke Therapeutics |
Biotechnology
Genetic Therapies, Antisense |
1.90B | 53 | -0.46 | 28 | 97 | - |
| BCRX BioCryst |
Biotechnology
Influenza Treatments, Rare Disease |
1.87B | 58 | 0.36 | 30 | 70 | - |
| ANAB AnaptysBio |
Biotechnology
Antibodies, Therapeutics |
1.86B | 70 | 0.38 | 40 | 99 | - |
| AUPH Aurinia |
Biotechnology
Autoimmune Therapies, Lupus |
1.85B | 60 | -0.05 | 33 | 81 | - |
| RLAY Relay Therapeutics |
Biotechnology
Oncology Drugs, Genetic Drugs |
1.83B | 53 | -0.15 | 88 | 98 | - |
| SLNO Soleno Therapeutics |
Biotechnology
Rare diseases, Tablets |
1.79B | 33 | -1.54 | 76 | 3 | - |
| RXRX Recursion |
Biotechnology
Drug Discovery, Clinical Trials |
1.79B | 17 | -1.28 | 43 | 5 | - |
| SRPT Sarepta |
Biotechnology
Exon-Skipping Injection, Gene |
1.77B | 16 | -0.74 | 43 | 9 | - |
| ZYME Zymeworks Common |
Biotechnology
Antibody Therapeutics, Cancer |
1.70B | 36 | -0.56 | 38 | 87 | - |
| SION Sionna |
Biotechnology
Drug Development, Clinical Trials |
1.68B | 48 | -0.74 | 80 | 92 | - |
| NVAX Novavax |
Biotechnology
Vaccines, Infectious Diseases |
1.67B | 49 | -0.63 | 33 | 88 | - |
| CAPR Capricor |
Biotechnology
Cell Therapies, Exosome Therapies |
1.66B | 36 | -0.84 | 33 | 99 | - |
| PHVS Pharvaris BV |
Biotechnology
Rare Disease Therapies, Angioedema |
1.65B | 45 | -0.64 | 80 | 82 | - |
| VCEL Vericel Ord |
Biotechnology
Cellular Therapies, Skin |
1.65B | 38 | -0.14 | 79 | 17 | - |
| AGIO Agios Pharm |
Biotechnology
Medicines, Anemias, Thalassemia |
1.63B | 22 | -0.70 | 38 | 27 | - |
| NANO Nanobiotix S.A |
Biotechnology
Cancer Therapy, Nanoparticles |
1.63B | 31 | -0.93 | 26 | 99 | - |
| NTLA Intellia |
Biotechnology
In Vivo, Ex Vivo, CRISPR, CAR-T |
1.59B | 36 | -0.88 | 36 | 84 | - |
| IMCR Immunocore Holdings |
Biotechnology
Cancer Drugs, Viral Cures |
1.56B | 21 | -1.13 | 77 | 24 | - |
| NRIX Nurix Therapeutics |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
1.55B | 38 | -0.15 | 88 | 69 | - |
| NUVB Nuvation Bio |
Biotechnology
Cancer Drugs, Lung Cancer, Solid |
1.54B | 39 | -1.18 | 33 | 87 | - |
| VIR Vir Biotechnology |
Biotechnology
Antibodies, Therapies, Vaccines |
1.48B | 34 | 0.16 | 32 | 94 | - |
| OCS Oculis Holding |
Biotechnology
Eye Treatments, Drug Candidates |
1.47B | 31 | -0.72 | 43 | 87 | - |
| MEDCL Medincell |
Biotechnology
Injectables, Pharmaceuticals |
1.46B | 52 | -0.42 | 37 | 57 | - |
| BHVN Biohaven |
Biotechnology
Neurological Therapies, Oncology |
1.45B | 20 | -2.12 | 88 | 4 | - |
| ARDX Ardelyx |
Biotechnology
IBS Therapy, Phosphate Reducer |
1.43B | 29 | -1.04 | 32 | 59 | - |
| KOD Kodiak Sciences |
Biotechnology
Retinal Therapeutics, Antibody |
1.42B | 57 | -0.78 | 88 | 99 | - |
| PGEN Precigen |
Biotechnology
Gene Therapies, Cell Therapies |
1.36B | 44 | -1.64 | 33 | 83 | - |
| ORIC Oric |
Biotechnology
Cancer Therapies, Drug |
1.35B | 46 | -1.37 | 83 | 79 | - |
| ATAI ATAI Life Sciences |
Biotechnology
Mental Health, Psychedelics |
1.34B | 29 | -1.37 | 28 | 85 | - |
| CRVS Corvus |
Biotechnology
Cancer Treatments, Immune |
1.32B | 44 | -0.57 | 72 | 99 | - |
| IMTX Immatics |
Biotechnology
Cancer Therapies, Cell Therapy |
1.32B | 38 | -0.65 | 38 | 88 | - |
| MBX MBX Biosciences |
Biotechnology
Peptide Therapies, Endocrine |
1.26B | 47 | -0.75 | 88 | 98 | - |
| BCAX Bicara |
Biotechnology
Cancer Drugs, Antibodies, Therapies |
1.24B | 46 | -1.30 | 88 | 89 | - |
| TSHA Taysha Gene |
Biotechnology
Gene Therapies, Nervous System |
1.23B | 47 | -0.80 | 88 | 91 | - |
| IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, TGF-ß |
1.23B | 38 | -0.98 | 33 | 91 | - |
| GLUE Monte Rosa |
Biotechnology
Drug Discovery, Cancer Treatments |
1.22B | 49 | -0.64 | 40 | 97 | - |
| MLTX MoonLake |
Biotechnology
Inflammatory Therapies, Skin |
1.20B | 18 | -1.70 | 77 | 7 | - |
| ALVO Alvotech |
Biotechnology
Biologics, Therapeutics |
1.19B | 14 | -0.82 | 36 | 2 | - |
| DBVT DBV Technologies |
Biotechnology
Allergy Treatments, Patches |
1.15B | 36 | -0.91 | 28 | 97 | - |
| CTMX CytomX Therapeutics |
Biotechnology
Oncology Drugs, Biologics |
1.14B | 44 | -1.36 | 36 | 99 | - |
| PHARM Pharming |
Biotechnology
Rare Disease Therapies, Protein |
1.08B | 53 | -0.97 | 55 | 78 | - |
| ABCL Abcellera Biologics |
Biotechnology
Antibody Drugs, Drug Discovery |
1.06B | 43 | -0.09 | 78 | 51 | - |
| GERN Geron |
Biotechnology
Cancer Drugs, Therapeutics |
1.06B | 20 | -1.36 | 32 | 58 | - |
| AVBP ArriVent |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
1.06B | 31 | -1.52 | 74 | 62 | - |
| SVRA Savara |
Biotechnology
Rare Diseases, Respiratory |
1.05B | 41 | -0.60 | 73 | 90 | - |
| BBOT BridgeBio Oncology |
Biotechnology
Small Molecules, Cancer Drugs |
1.01B | 20 | -1.80 | 88 | 14 | - |
| INBX Inhibrx |
Biotechnology
Biologics, Therapeutics, Cancer |
1,000M | 39 | -0.47 | 40 | 99 | - |
| CMPX Compass |
Biotechnology
Tovecimig, CTX-471, CTX-8371 |
962M | 44 | -1.00 | 73 | 94 | - |
| VLA Valneva SE |
Biotechnology
Vaccines, Infectious diseases |
958M | 36 | -0.09 | 33 | 90 | - |
| GHRS GH Research |
Biotechnology
Depression Treatments, Drug |
953M | 42 | -0.77 | 73 | 78 | - |
| OPK Opko Health |
Biotechnology
Diagnostics, Pharmaceuticals |
914M | 14 | -0.63 | 33 | 15 | - |
| URGN UroGen Pharma |
Biotechnology
Cancer Drugs, Hydrogel Technology |
898M | 33 | -0.96 | 34 | 64 | - |
| SANA Sana Biotechnology |
Biotechnology
Cell Therapy, Diabetes Treatment |
897M | 20 | -1.46 | 73 | 31 | - |
| XNCR Xencor |
Biotechnology
Antibodies, Biologics |
880M | 19 | -0.99 | 43 | 34 | - |
| SPRY ARS |
Biotechnology
Neffy, Nasal, Epinephrine |
879M | 11 | -1.29 | 38 | 10 | - |
| CDNA CareDx |
Biotechnology
Transplant Testing, Gene |
875M | 28 | -0.26 | 38 | 30 | - |
| SLS Sellas Life |
Biotechnology
Cancer drugs, Immunotherapy, Small |
858M | 46 | -0.85 | 76 | 99 | - |
| MPLT MapLight |
Biotechnology
CNS Treatments, Drug Candidates |
857M | 29 | -1.14 | 78 | 22 | - |
| KALV Kalvista |
Biotechnology
Drug Therapies, Small Molecules |
856M | 39 | -1.01 | 26 | 68 | - |
| JANX Janux Therapeutics |
Biotechnology
Cancer Drugs, Immunotherapies |
844M | 11 | -1.08 | 28 | 8 | - |
| ABUS Arbutus Biopharma |
Biotechnology
Hepatitis B, RNAi, Immune Response |
839M | 30 | -0.92 | 33 | 58 | - |
| ANNX Annexon |
Biotechnology
Biologics, Small Molecules |
836M | 56 | -0.61 | 80 | 96 | - |
| OCGN Ocugen |
Biotechnology
Gene Therapy, Vaccines, Cell |
803M | 48 | -0.63 | 82 | 98 | - |
| CGEM Cullinan Oncology |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
797M | 43 | -1.02 | 68 | 92 | - |
| KURA Kura Oncology |
Biotechnology
Cancer Drugs, Leukemia Treatment |
764M | 18 | -1.19 | 39 | 50 | - |
| CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous-Cell, Uveal |
760M | 43 | -0.52 | 54 | 35 | - |
| BTX BlackRock |
Biotechnology
Technology, Private Equity |
727M | 21 | 0.23 | 57 | 43 | 13.3% |
| LXRX Lexicon |
Biotechnology
Drugs, Treatments, Research |
716M | 39 | -0.49 | 32 | 98 | - |
| DRUG Bright Minds |
Biotechnology
Drug Development, Serotonin |
705M | 47 | -0.67 | 88 | 92 | - |
| PRME Prime Medicine |
Biotechnology
Gene Editing, Genetic Therapies |
670M | 44 | -1.55 | 78 | 84 | - |
| MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
655M | 38 | -1.36 | 87 | 3 | - |
| DSGN Design Therapeutics |
Biotechnology
Small Molecules, Genetic Diseases |
626M | 50 | -0.48 | 88 | 96 | - |
| TECX Tectonic |
Biotechnology
Biologics, Proteins, Antibodies |
625M | 35 | -0.16 | 88 | 95 | - |
| MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapies, Ocular Treatments |
619M | 21 | -0.97 | 33 | 33 | - |
| DRTS Alpha Tau Medical |
Biotechnology
Cancer Therapy, Radiation Therapy |
611M | 47 | -0.42 | 88 | 97 | - |
| REPL Replimune |
Biotechnology
Cancer Therapies, Immunotherapies |
590M | 11 | -1.53 | 37 | 25 | - |
| IMMX Immix Biopharma |
Biotechnology
Cell Therapy, Cancer Treatment |
589M | 42 | -0.77 | 28 | 99 | - |
| ESPR Esperion |
Biotechnology
Cholesterol Medication |
583M | 37 | -1.25 | 26 | 76 | - |
| VOR Vor Biopharma |
Biotechnology
Cell Therapies, Gene Therapies |
570M | 27 | -1.52 | 88 | 80 | - |
| SLDB Solid Biosciences |
Biotechnology
Gene Therapy, Dystrophy |
570M | 43 | -0.88 | 83 | 88 | - |
| ZVRA Zevra Therapeutics |
Biotechnology
KP1077, Celiprolol, AZSTARYS |
556M | 55 | -0.97 | 33 | 71 | - |
| IRWD Ironwood |
Biotechnology
GI Therapies, Rare Disease, Pain |
550M | 53 | -1.04 | 27 | 98 | - |
| ALLO Allogene |
Biotechnology
CD19, B-cell, leukemia, lymphoma |
539M | 35 | -1.14 | 76 | 92 | - |
| KYTX Kyverna |
Biotechnology
Cell Therapy, Autoimmune Disease |
533M | 46 | -0.49 | 84 | 98 | - |
| RCKT Rocket |
Biotechnology
Gene Therapy, AAV, Lentiviral |
514M | 28 | -1.03 | 74 | 80 | - |
| VNDA Vanda |
Biotechnology
Medications, Therapies |
508M | 34 | -0.83 | 38 | 94 | - |
| RIGL Rigel |
Biotechnology
Cancer Drugs, Blood Disorders |
490M | 40 | -0.94 | 38 | 22 | - |
| LXEO Lexeo |
Biotechnology
Gene Therapy, Cardiovascular |
486M | 49 | -1.30 | 85 | 63 | - |
| TRDA Entrada |
Biotechnology
Drug Delivery, RNA Therapeutics |
486M | 36 | -0.97 | 87 | 89 | - |
| FDMT 4D Molecular |
Biotechnology
Gene Therapy, Drug Development |
485M | 53 | -0.24 | 84 | 91 | - |
| IVVD Invivyd |
Biotechnology
Antibodies, Vaccines, Treatments |
482M | 38 | -1.38 | 39 | 82 | - |
| DBV DBV Technologies |
Biotechnology
Peanut Patch, Milk Patch |
482M | 38 | -0.92 | 31 | 97 | - |
| CLYM Climb Bio |
Biotechnology
Antibodies, Therapies, Diseases |
479M | 43 | -0.42 | 73 | 99 | - |
| PRTA Prothena |
Biotechnology
Antibody, Vaccine |
462M | 20 | -0.78 | 73 | 37 | - |
| ABSI Absci |
Biotechnology
Drug Discovery, AI, Antibodies |
456M | 15 | -1.15 | 28 | 27 | - |
| ALT Altimmune |
Biotechnology
Obesity Treatments, Liver Disease |
453M | 11 | -1.31 | 43 | 6 | - |
| ASMB Assembly |
Biotechnology
Antivirals, Herpes Treatment |
451M | 43 | -0.54 | 38 | 88 | - |
| MYGN Myriad Genetics |
Biotechnology
Cancer Tests, Health Screens |
447M | 15 | -1.42 | 33 | 6 | - |